文献速递免疫规划传染病防控与疫情报告

既往流感疫苗接种与COVID-19感染风险和严重程度的关联:系统综述与Meta分析

The Association Between Previous Influenza Vaccination and COVID-19 Infection Risk and Severity: A Systematic Review and Meta-analysis.
PubMed 文献 · Am J Prev Med · 2022-03-15

该系统综述与Meta分析检索8个数据库至2021年8月,纳入23篇已发表文章共1,037,445名参与者,评估流感疫苗接种对COVID-19的影响。结果显示流感疫苗接种与COVID-19感染风险降低(RR=0.83,95%CI=0.76,0.90)和住院风险降低(RR=0.71,95%CI=0.59,0.84)相关,但与ICU入住和死亡风险无显著关联;四价流感疫苗可能与感染风险降低相关(RR=0.74,95%CI=0.65,0.84)。

要点

  • 流感疫苗接种与COVID-19感染风险降低相关(RR=0.83,95%CI=0.76,0.90)。
  • 流感疫苗接种与COVID-19住院风险降低相关(RR=0.71,95%CI=0.59,0.84)。
  • 流感疫苗接种与ICU入住和死亡风险无显著关联。

核心结论

  • 流感疫苗接种与COVID-19易感性降低或疾病严重程度降低相关,流感疫苗接种可能降低COVID-19风险并改善临床结局。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Web of Science、Cochrane Library、Embase、中国知网、 SinoMed、万方数据知识服务平台和中国科技期刊VIP数据库,检索时间从数据库建库至2021年8月,纳入23篇已发表文章共1,037,445名参与者。

主要发现

  • 流感疫苗接种与COVID-19感染风险降低相关(RR=0.83,95%CI=0.76,0.90)。
  • 流感疫苗接种与COVID-19住院风险降低相关(RR=0.71,95%CI=0.59,0.84)。
  • 流感疫苗接种与ICU入住风险无显著关联(RR=0.93,95%CI=0.64,1.36)。
  • 流感疫苗接种与死亡风险无显著关联(RR=0.83,95%CI=0.68,1.01)。
  • 四价流感疫苗可能与COVID-19感染风险降低相关(RR=0.74,95%CI=0.65,0.84)。

关键数值与推荐

  • 采用合并RR及95%CI评估流感疫苗接种对COVID-19的影响,采用I²值评估异质性,若I²>50%则采用随机效应模型进行合并。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The association between influenza vaccination and COVID-19 remains controversial. This meta-analysis aimed to investigate whether influenza vaccination reduces the susceptibility and severity of SARS-CoV-2 infection. METHODS: A systematic literature search of PubMed, Web of Science, the Cochrane Library, Embase, China National Knowledge Infrastructure, SinoMed, Wanfang Data Knowledge Service Platform, and China Science and Technology Journal VIP Database was conducted from database inception to August 2021. The pooled RR with 95% CI was used to estimate the effect of influenza vaccination on COVID-19. The I2 value was used to assess heterogeneity. If I2>50%, the random-effects model was used as the pooling method. RESULTS: A total of 23 published articles with 1,037,445 participants were identified. This meta-analysis showed that influenza vaccination was associated with reduced risk of COVID-19 infection (RR=0.83, 95% CI=0.76, 0.90) and hospitalization (RR=0.71, 95% CI=0.59, 0.84), although not significantly associated with intensive care unit admission and death (risk of intensive care unit admission: RR=0.93, 95% CI=0.64, 1.36; risk of death: RR=0.83, 95% CI=0.68, 1.01). Further analysis suggested that the tetravalent influenza vaccine may be associated with a reduced risk of COVID-19 infection (RR=0.74, 95% CI=0.65, 0.84). DISCUSSION: The results suggest that influenza vaccination is associated with reduced susceptibility to or disease severity of COVID-19 and that influenza vaccination may reduce the risk of COVID-19 and improve clinical outcomes.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Su W, Wang H, Sun C, et al. The Association Between Previous Influenza Vaccination and COVID-19 Infection Risk and Severity: A Systematic Review and Meta-analysis. Am J Prev Med. 2022. PMID: 35410774. doi:10.1016/j.amepre.2022.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。